Nephron Pharmaceuticals Corporation
- Home
- Companies
- Nephron Pharmaceuticals Corporation
- Products
- Nephron - Budesonide Inhalation ...
Nephron - Budesonide Inhalation Suspension 0.25 mg / 2 mL
Budesonide Inhalation Suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age.
Most popular related searches
Budesonide Inhalation Suspension 0.25 mg / 2mL
- 0487-9601-01 (30 individually wrapped and barcoded vials)
- 0487-9601-30 (30 bulk wrapped vials)
Each unit dose is:
- Sterile unit dose
- Bar coded
- Foil pouched and embossed vials for easy identification
